Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 46 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
451 18.4 months Metastatic, castration-resistant prostate cancer, bone metastases 5 Chemotherapy
Daniel den Hoed Cancer Center Netherlands 11/2012
Treatment Details: Patients: This study involved metastatic castration-resistant prostate cancer patients with metastases to the bone who were divided into two separate treatment groups. There were 301 patie
 
452 18.4 months Malignant pleural mesothelioma 5 Chemotherapy
Radiation
Surgery
Antwerp University Hospital Belgium 12/2010
Treatment Details: Patients: This phase 2 study involved 59 malignant pleural mesothelioma patients. The median patient age was 57 years and 46 were males. Treatment: Patients were treated with surgery,
 
453 18.4 months Castration-resistant prostate cancer 5 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 9/2012
Treatment Details: Patients: This phase 3 study involved 800 men with castration-resistant prostate cancer who had undergone chemotherapy. The median patient age was 69 years. Treatment: Patients were tr
 
454 18.3 months Advanced NSCLC 5 Chemotherapy
Guangdong Lung Cancer Institute, Guangdong General Hospital China 9/2012
Treatment Details: Patients: This phase 3 study involved untreated advanced non-small cell lung cancer patients who were divided into two separate treatment groups. Of the total patient population, 78.5% wer
 
455 18.3 months Newly diagnosed GBM 5 Chemotherapy
Immunotherapy
Radiation
University Hospital Leuven Belgium 11/2012
Treatment Details: Patients: This phase 2 study involved 77 newly diagnosed glioblastoma patients with a median age of 57 year; 48 were male. Treatment: Patients were treated with radiation therapy, chemo
 
456 18.3 months NSCLC 5 Biologic therapy
Chemotherapy
Chinese University of Hong Kong China 7/2013
Treatment Details: Patients: This phase 3 study involved non-small cell lung cancer patients who were divided into two separate treatment groups. Group A had 226 patients with a median age of 59.0 years and
 
457 18.3 months Stage III NSCLC 4 Chemotherapy
Radiation
University of Chicago Medical Center United States 10/2002
Treatment Details: Patients: This Phase II study involved a total of 175 patients with stage III non-small cell lung cancer. Patients were divided into three groups. Group A contained 62 patients. Group B c
 
458 18.3 months Newly diagnosed GBM 4 Chemotherapy
Radiation
Istituto Nazionale Neurologico Carlo Besta Italy 12/2002
Treatment Details: Patients: This study involved 30 newly diagnosed patients with glioblastoma multiforme. The patients were divided into two groups (A and B) of 15 patients each. Treatment: Patients in Gr
 
459 18.2 months metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Centre Rene Gauducheau France 1/2006
Treatment Details: Patients: This Phase II study involved 64 patients with metastatic colorectal cancer (49 patients had colon cancer and 15 patients had rectal cancer.) Thirty-six patients were men, and twen
 
460 18.2 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Centre Rene Gauducheau France 1/2006
Treatment Details: Patients: This Phase II study involved 64 patients with metastatic colorectal cancer (49 patients had colon cancer and 15 patients had rectal cancer.) Thirty-six patients were men, and twen
 
Page 46 of 187  | Previous Page  | Next Page